Therefore, we developed a targeted theranostic biomimetic drug delivery platform using hRBCm-coated anti-EpCAM functionalized Na131I radiolabeled PLGA nanoparticles (EINPs) to treat MCF-7 breast-cancer cells. Here, EPCAM is linked to breast carcinoma.